Liver Cancer – Identifying and Commercializing First-in-Class Innovation

The liver cancer pipeline contains 238 products in active development, approximately 47% of which are first-in-class. The percentage of the pipeline devoted to innovative products is considerably larger than both the industry and oncology average, which is a promising sign for novel therapeutics reaching the liver cancer market. The contrast between the market and pipeline… Read More Liver Cancer – Identifying and Commercializing First-in-Class Innovation

Rheumatoid Arthritis Market to reach $80.7 billion in 2020 – A Crowded Market Characterized by Modest Growth

Increasingly Crowded Market for Second-Line Therapies Improving Treatment Options for Moderate-to-Severe Rheumatoid Arthritis Patients Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone erosion over many years, and disease progression results in stiffness and pain, especially in the hands… Read More Rheumatoid Arthritis Market to reach $80.7 billion in 2020 – A Crowded Market Characterized by Modest Growth

Antibiotics – Identifying and Commercializing First-in-Class Innovation

An Extensive Developmental Pipeline, but Limited First in Class Innovation The antibiotics pipeline is very active, with 741 products in development. Of these, the majority (85%) are at the Discovery or Preclinical stages and have not yet entered human trials. Such a high proportion of drugs at the earliest stages of development would, in other… Read More Antibiotics – Identifying and Commercializing First-in-Class Innovation

Colorectal Cancer Therapeutics Market to grow to $9.4 billion by 2020

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 – Increased Uptake of High Priced Drugs to Offset the Impact of Generics Summary “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 – Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics… Read More Colorectal Cancer Therapeutics Market to grow to $9.4 billion by 2020

Alzheimer’s Disease – Identifying and Commercializing First-in-Class Innovation

Large and Innovative Pipeline The active Alzheimer’s Disease (AD) pipeline is populated with 583 products, with a highly diverse range of molecular targets. GBI Research analysis revealed a high degree of innovation in this indication, with 46% of the pipeline being first-in-class products, acting on over 40 first-in-class molecular targets. In addition, the pipeline is… Read More Alzheimer’s Disease – Identifying and Commercializing First-in-Class Innovation

Milestone in world of Healthcare : eHealth !!

Defining eHealth:  eHealth refers to the use of information and communications technologies in healthcare. eHealth covers a lot of field, which is why digital health industry experts often challenge exactly what the term means – and to add to the discussion, it’s also frequently used as a synonym for Health IT. As per the definition… Read More Milestone in world of Healthcare : eHealth !!

Disposable syringe industry market can help in curing 21 million hepatitis B infections around the world.

For many decades the reusable syringe was seen as the best option, and as recently as 1998 WHO was still advocating that certain types of syringes and needles be reused up to 200 times as part of vaccination programmes. But opinion began to change, and a study by WHO in 2000 found that of the… Read More Disposable syringe industry market can help in curing 21 million hepatitis B infections around the world.